1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Adenocarcinoma, Basal Cell in 14 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 8 (57.14) | 18.2507 |
2000's | 6 (42.86) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Axelrad, TW; Bazan, HE; Bazan, NG; Deo, DD; Hunt, JD; Ottino, P; Van Kirk, J | 1 |
Baldi, E; Bonaccorsi, L; Cioppi, F; Granchi, S; Luconi, M; Maggi, M; Muratori, M; Peri, A | 1 |
Choi, IH; Choi, JH; Im, SY; Jung, B; Ko, HM; Lee, HK; Lee, HS; Park, SJ; Seo, KH | 1 |
Beer, DG; Behar, J; Cao, W; Chin, YE; Lambeth, D; Si, J; Wands, J | 1 |
Baldi, E; Bonaccorsi, L; Carloni, V; Finetti, G; Forti, G; Laffi, G; Maggi, M; Muratori, M; Serio, M | 1 |
Baldi, E; Bonaccorsi, L; Finetti, G; Forti, G; Luconi, M; Maggi, M; Muratori, M; Serio, M; Susini, T | 1 |
Baldi, E; Bonaccorsi, L; Cresci, B; Finetti, G; Forti, G; Giannini, S; Luconi, M; Maggi, M; Rotella, CM; Serio, M | 1 |
Baldi, E; Bonaccorsi, L; Forti, G; Luconi, M; Maggi, M; Muratori, M; Serio, M | 1 |
Chertov, OIu; Golubeva, TS; KiselevskiÄ, MV; Tuguz, AR | 1 |
Fukunaga, K; Miyamoto, E; Miyazaki, K; Munir, I; Okamura, H | 1 |
Calafat, J; Hiemstra, PS; Hordijk, PL; Janssen, H; Mul, FP; Roos, D; van Wetering, S; Zuurbier, AE | 1 |
Baldi, E; Bonaccorsi, L; Cioppi, F; Forti, G; Granchi, S; Luconi, M; Maggi, M; Miele, L; Mini, E; Muratori, M; Peri, A; Pesciullesi, A; Serio, M | 1 |
Andrade, SP; Bakhle, YS; Hart, I; Piper, PJ | 1 |
Bolvacheva, AV; Bykovskaya, SN; Bykovsky, AF; Khaylenko, VA; Kiselevsky, MV | 1 |
2 review(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Adenocarcinoma, Basal Cell
Article | Year |
---|---|
The effects of an autocrine loop mediated by platelet-activating factor (PAF) in HEC-1A cells are reverted by uteroglobin.
Topics: Adenocarcinoma; Animals; Autocrine Communication; Cell Division; Cell Line, Tumor; Endometrial Neoplasms; Female; Humans; Mitogen-Activated Protein Kinases; Phospholipases A; Platelet Activating Factor; Protein Kinase C; Uteroglobin | 2003 |
Platelet-activating factor in human endometrium.
Topics: Adenocarcinoma; Endometrium; Female; Growth Substances; Humans; Platelet Activating Factor; Tumor Cells, Cultured; Uterine Neoplasms | 1994 |
12 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Adenocarcinoma, Basal Cell
Article | Year |
---|---|
Platelet-activating factor (PAF) induces activation of matrix metalloproteinase 2 activity and vascular endothelial cell invasion and migration.
Topics: Adenocarcinoma; Cell Line, Tumor; Cell Movement; Cells, Cultured; Culture Media, Conditioned; Endothelial Cells; Enzyme Activation; Enzyme Precursors; Gene Expression Regulation; Growth Substances; Humans; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinases, Membrane-Associated; Membrane Proteins; Metalloendopeptidases; Platelet Activating Factor; Platelet Membrane Glycoproteins; Prostatic Neoplasms; Receptors, G-Protein-Coupled; RNA, Messenger; Second Messenger Systems; Tissue Inhibitor of Metalloproteinase-2; Umbilical Veins | 2004 |
Estrogen enhances angiogenesis through a pathway involving platelet-activating factor-mediated nuclear factor-kappaB activation.
Topics: Adenocarcinoma; Animals; Endometrial Neoplasms; Estradiol Congeners; Female; Fibroblast Growth Factor 2; Interleukin-1; Interleukin-8; Mice; Mice, Inbred BALB C; Neovascularization, Pathologic; NF-kappa B; Phospholipases A; Phospholipases A2; Platelet Activating Factor; RNA, Messenger; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A | 2004 |
STAT5 mediates PAF-induced NADPH oxidase NOX5-S expression in Barrett's esophageal adenocarcinoma cells.
Topics: Adenocarcinoma; Arachidonic Acids; Barrett Esophagus; Cell Line, Tumor; Enzyme Inhibitors; Esophageal Neoplasms; Flavonoids; Humans; Hydrogen Peroxide; Hydrogen-Ion Concentration; MAP Kinase Kinase 1; Membrane Proteins; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; NADPH Oxidase 5; NADPH Oxidases; Phospholipases A2, Cytosolic; Phospholipid Ethers; Phosphorylation; Platelet Activating Factor; Platelet Aggregation Inhibitors; Promoter Regions, Genetic; RNA Interference; RNA, Small Interfering; Signal Transduction; STAT5 Transcription Factor; Transfection; Up-Regulation | 2008 |
Platelet-activating factor mediates an autocrine proliferative loop in the endometrial adenocarcinoma cell line HEC-1A.
Topics: Acetyl-CoA C-Acetyltransferase; Adenocarcinoma; Binding, Competitive; Calcium; Cell Count; Cell Cycle; Cell Division; Chromatography, Gas; Endometrial Neoplasms; Female; Furans; Humans; Platelet Activating Factor; Proto-Oncogene Proteins c-fos; RNA; RNA, Messenger; Tumor Cells, Cultured | 1994 |
Platelet-activating factor enhances production of insulin-like growth factor binding proteins in a human adenocarcinoma cell line (HEC-1A)
Topics: Adenocarcinoma; Autoradiography; Blotting, Northern; Blotting, Western; Humans; Insulin-Like Growth Factor Binding Proteins; Insulin-Like Growth Factor I; Insulin-Like Growth Factor II; Platelet Activating Factor; Somatomedins; Tumor Cells, Cultured | 1996 |
Protein tyrosine kinase, mitogen-activated protein kinase and protein kinase C are involved in the mitogenic signaling of platelet-activating factor (PAF) in HEC-1A cells.
Topics: Adenocarcinoma; Calcium-Calmodulin-Dependent Protein Kinases; Cell Division; Enzyme Activation; Humans; Mitogen-Activated Protein Kinase 1; Phosphorylation; Platelet Activating Factor; Protein Kinase C; Protein-Tyrosine Kinases; Signal Transduction; Thymidine; Tumor Cells, Cultured | 1997 |
[Determination of the nucleosomal fragmentation of DNA of ACL cells during their incubation with human platelets].
Topics: Adenocarcinoma; Blood Platelets; Cytotoxicity Tests, Immunologic; DNA Fragmentation; Humans; Lung Neoplasms; Nucleosomes; Platelet Activating Factor; Tumor Cells, Cultured | 1997 |
Mitogen-activated protein kinase activation and regulation of cyclooxygenase 2 expression by platelet-activating factor and hCG in human endometrial adenocarcinoma cell line HEC-1B.
Topics: Adenocarcinoma; Androstadienes; Antineoplastic Agents, Hormonal; Chorionic Gonadotropin; Cyclic AMP; Cyclooxygenase 2; Endometrial Neoplasms; Enzyme Activation; Enzyme Inhibitors; Estradiol; Female; Flavonoids; Humans; Isoenzymes; Isoquinolines; Medroxyprogesterone Acetate; Membrane Proteins; Mitogen-Activated Protein Kinase Kinases; Mitogen-Activated Protein Kinases; Mitogens; Platelet Activating Factor; Prostaglandin-Endoperoxide Synthases; Protein Kinase Inhibitors; Signal Transduction; Sulfonamides; Thionucleotides; Tumor Cells, Cultured; Wortmannin | 1999 |
Sequential migration of neutrophils across monolayers of endothelial and epithelial cells.
Topics: Adenocarcinoma; Bronchi; CD18 Antigens; Cell Communication; Cell Line, Transformed; Cell Polarity; Cells, Cultured; Chemotaxis, Leukocyte; Coculture Techniques; Complement C5a; Endothelium, Vascular; Epithelial Cells; Humans; Interleukin-1; Interleukin-6; Interleukin-8; Lung; Lung Neoplasms; Microscopy, Electron; Models, Biological; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Platelet Activating Factor; Platelet Endothelial Cell Adhesion Molecule-1; Recombinant Proteins; Tumor Cells, Cultured; Umbilical Veins | 2000 |
Uteroglobin reverts the transformed phenotype in the endometrial adenocarcinoma cell line HEC-1A by disrupting the metabolic pathways generating platelet-activating factor.
Topics: Acetyltransferases; Adenocarcinoma; Arachidonic Acid; Cell Cycle; Cell Division; Cell Membrane; Cell Transformation, Neoplastic; Endometrial Neoplasms; Female; Humans; Kinetics; Phospholipases A; Platelet Activating Factor; Recombinant Proteins; Reverse Transcriptase Polymerase Chain Reaction; Transcription, Genetic; Transfection; Tumor Cells, Cultured; Uteroglobin | 2000 |
Effects of tumour cells on angiogenesis and vasoconstrictor responses in sponge implants in mice.
Topics: Adenocarcinoma; Angiotensin II; Animals; Blood Vessels; Colonic Neoplasms; Endothelins; Epinephrine; Half-Life; Male; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Neovascularization, Pathologic; Platelet Activating Factor; Polyurethanes; Prostheses and Implants; Serotonin; Tumor Cells, Cultured; Vasoconstrictor Agents; Xenon Radioisotopes | 1992 |
Platelet-mediated cytotoxicity and its enhancement by platelet activating factor.
Topics: Adenocarcinoma; Adult; Aged; Antibody-Dependent Cell Cytotoxicity; Blood Platelets; Humans; Middle Aged; Neoplasms; Platelet Activating Factor; Tumor Cells, Cultured | 1991 |